Standout Papers

Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi st... 2014 2026 2018 2022 1.7k
  1. Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies (2014)
    Ivan Diamond, Robert C. Grant et al. Journal of Clinical Epidemiology

Citation Impact

Citing Papers

Multiplex PCR: Optimization and Application in Diagnostic Virology
2000
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid
2007 Standout
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
2013 StandoutNobel
Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non‐alcoholic fatty liver disease
2013
To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
2002
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis
2017
Effect of preventive zinc supplementation on linear growth in children under 5 years of age in developing countries: a meta-analysis of studies for input to the lives saved tool
2011
Cancer Statistics, 2021
2021 Standout
A Comprehensive Review of Noninvasive Liver Fibrosis Tests in Pediatric Nonalcoholic Fatty Liver Disease
2015
Chimerism of the Transplanted Heart
2002 Standout
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Mechanism of liver allograft rejection: The indirect recognition pathway
1997
Association Between Puberty and Features of Nonalcoholic Fatty Liver Disease
2012
Nitric oxide is a potential mediator of hepatic inflammation and fibrogenesis in autoimmune hepatitis
2014
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2015
Fatal Autoimmune Hepatitis Induced by Concurrent Loss of Naturally Arising Regulatory T Cells and PD-1-Mediated Signaling
2008 StandoutNobel
Hepatitis C Virus Infection
2001 Standout
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients
2013
Burden of liver diseases in the world
2018 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Endpoints and clinical trial design for nonalcoholic steatohepatitis
2011
CYTOMEGALOVIRUS INFECTION AND DONOR/RECIPIENT HLA ANTIGENS: INTERDEPENDENT CO-FACTORS IN PATHOGENESIS OF VANISHING BILEDUCT SYNDROME AFTER LIVER TRANSPLANTATION
1988
Autoimmune hepatitis
2010
Chronic Liver Disease in Ethiopia with a Particular Focus on the Etiological Spectrums: A Systematic Review and Meta‐Analysis of Observational Studies
2021
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race
2006
Early intragraft inflammatory events of liver allografts leading to chronic rejection
1995
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis
2020
Recent advances in the molecular biology of hepatitis C virus
2001
Pathological Features of Fatty Liver Disease
2014
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With Fibrosis
2010
Unexplained chronic liver disease in Ethiopia: a cross-sectional study
2018
The role of resistance in HCV treatment
2012
Cell Mediators of Autoimmune Hepatitis and Their Therapeutic Implications
2014
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2
2004 StandoutNobel
International Liver Transplant Society Practice Guidelines
2016
Defining Advance Care Planning for Adults: A Consensus Definition From a Multidisciplinary Delphi Panel
2017 Standout
Non-alcoholic fatty liver disease
2021 Standout
Randomized controlled trial of the effect of zinc supplementation on the mental development of Bangladeshi infants
2001
HCV NS5A inhibits interferon-α signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines
2006
Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy
2003 StandoutNobel
Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis
1989
2 Inhibitors of Human Leukocyte Elastase
1994
Structural and mechanistic insights into hepatitis C viral translation initiation
2006 StandoutNobel
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Global burden of liver disease: 2023 update
2023 Standout
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-κB activation in rat hepatocytes
1999
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
2009
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Past, present and future perspectives in nonalcoholic fatty liver disease
2019
Osteoarthritis
2019 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Liver Biopsy
2001 Standout
Developmental potential in the first 5 years for children in developing countries
2007 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Virtual Reality for Health Professions Education: Systematic Review and Meta-Analysis by the Digital Health Education Collaboration
2018 Standout
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
2010
Guidelines for the management of inflammatory bowel disease in adults
2004
Peginterferon alone or with ribavirin enhances HCV-specific CD4+ T-helper 1 responses in patients with chronic hepatitis C
2002
Replication of hepatitis C virus
2007 StandoutNobel
Molecular Recognition of Protein−Ligand Complexes:  Applications to Drug Design
1997 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients
2017 StandoutNobel
The Evolving Challenge of Infections in Cirrhosis
2021
Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.
2013
Genetic Interactions between Hepatitis C Virus Replicons
2004 StandoutNobel
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells
1998 StandoutNobel
Primary Biliary Cirrhosis
1987 Standout
Unique Features of Hepatitis C Virus Capsid Formation Revealed by De Novo Cell-Free Assembly
2004
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Lipodystrophy Due to Adipose Tissue–Specific Insulin Receptor Knockout Results in Progressive NAFLD
2016
Early intragraft inflammatory events of liver allografts leading to chronic rejection
1995
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Experimental Transmission of Hepatitis C Virus–Associated Fulminant Hepatitis to a Chimpanzee
1999
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
1997
Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study
2021
Screening for Hepatitis C Virus Infection in Adolescents and Adults
2020
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
What Do People With Knee or Hip Osteoarthritis Need to Know? An International Consensus List of Essential Statements for Osteoarthritis
2014
TROPHIC AND CYTOPROTECTIVE NUTRITION FOR INTESTINAL ADAPTATION, MUCOSAL REPAIR, AND BARRIER FUNCTION
2003
Epidemiology and surveillance of autoimmune hepatitis in Asia
2022
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Clinical Prediction Rules for Children: A Systematic Review
2011
Autoimmune Hepatitis
2006
The pathogenesis of primary biliary cirrhosis
1985
Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
2012
Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology
2021
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.
1981
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout

Works of Simon C. Ling being referenced

Derivation of a Clinical Prediction Rule for the Noninvasive Diagnosis of Varices in Children
2010
Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B
2015
Autoimmune hepatitis
2018
Nonalcoholic Steatohepatitis in Children
2009
Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
2014 Standout
Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016
2016
Zinc and rehabilitation from severe protein-energy malnutrition: higher-dose regimens are associated with increased mortality
1998
Diagnosis and Management of Autoimmune Hepatitis
2010
Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management
2015
Immunologic Mechanisms of Hepatic Allograft Rejection
1992
Treatment challenges and investigational opportunities in autoimmune hepatitis
2004
Nutrition in inflammatory bowel disease
2000
Cutting edge issues in autoimmune hepatitis
2016
The Evaluation of Hepatic Fibrosis Scores in Children with Nonalcoholic Fatty Liver Disease
2014
Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection
2001
Relationship of Pretransplant Hepatobiliary Disease to Bile Duct Damage Occurring in the Liver Allograft
1983
Simultaneous detection of both hepatitis B virus DNA and hepatitis C virus RNA using a combined one-step polymerase chain reaction technique
1995
Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure
1996
1213 EFFICACY AND SAFETY OF MERICITABINE (MCB) IN COMBINATION WITH PEG-IFNa-2A/RBV IN G1/4 TREATMENT NAIVE HCV PATIENTS: FINAL ANALYSIS FROM THE PROPEL STUDY
2012
Congenital Portosystemic Shunt
2013
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
2019
Virtual reality simulation training for health professions trainees in gastrointestinal endoscopy
2012
Histopathology of Early and Late Human Hepatic Allograft Rejection: Evidence of Progressive Destruction of Interlobular Bile Ducts
1985
Metabolism of Intact and Desialylated α1-Antitrypsin
1978
Relations of Steatosis Type, Grade, and Zonality to Histological Features in Pediatric Nonalcoholic Fatty Liver Disease
2011
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study
2019
Viral, host and interferon‐related factors modulating the effect of interferon therapy for hepatitis C virus infection
2001
Rankless by CCL
2026